| Entry |
|
|---|
| Name |
Nevirapine (JAN/USP/INN);
Viramune (TN) |
|---|
| Abbr |
NVP |
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C15H14N4O
|
|---|
| Exact mass |
266.1168
|
|---|
| Mol weight |
266.2979
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antiviral
DG01889 Non-nucleoside reverse transcriptase inhibitor (NNRTI)
DG03107 Anti-HIV agent
DG01656 HIV reverse transcriptase inhibitor
Metabolizing enzyme substrate
DG02919 CYP2B6 substrate
DG01644 CYP2D6 substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
|
|---|
| Remark |
| Therapeutic category: | 6250 |
|
|---|
| Efficacy |
Antiviral, Reverse transcriptase inhibitor |
|---|
| Disease |
|
|---|
| Target |
HIV-1 reverse transcriptase [KO: K24802] |
|---|
| Pathway |
|
|---|
| Metabolism |
Enzyme: CYP3A4 [HSA: 1576], CYP2B6 [HSA: 1555], CYP2D6 [HSA: 1565]
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AG Non-nucleoside reverse transcriptase inhibitors
J05AG01 Nevirapine
D00435 Nevirapine (JAN/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Antivirals
Anti-HIV Agents, Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI)
Nevirapine
D00435 Nevirapine (JAN/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D00435 Nevirapine (JAN/USP/INN)
Drug groups [BR:br08330]
Antiviral
DG01889 Non-nucleoside reverse transcriptase inhibitor (NNRTI)
D00435 Nevirapine
DG03107 Anti-HIV agent
DG01656 HIV reverse transcriptase inhibitor
D00435 Nevirapine
Metabolizing enzyme substrate
DG02919 CYP2B6 substrate
D00435 Nevirapine
DG01644 CYP2D6 substrate
D00435 Nevirapine
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D00435 Nevirapine
Drug classes [BR:br08332]
Antiviral
DG03107 Anti-HIV agent
D00435 Nevirapine
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HIV reverse transcriptase inhibitor
D00435 Nevirapine (JAN/USP/INN) <JP/US>
Antimicrobials abbreviations [BR:br08327]
Antivirals
Genome replication inhibitor
HIV reverse transcriptase inhibitor
D00435 Nevirapine (JAN/USP/INN)
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D00435
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00435
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 20
1 C5x C 16.4500 -10.0100
2 C8y C 15.6100 -8.8900
3 C8y C 15.9600 -7.5600
4 N1y N 17.2200 -7.0000
5 N1x N 17.8500 -10.0100
6 C8y C 18.4800 -7.6300
7 C8y C 18.7600 -8.9600
8 N5x N 14.9100 -6.5800
9 C8x C 13.5800 -7.0000
10 C8x C 13.2300 -8.3300
11 C8x C 14.2800 -9.3100
12 C8y C 20.0900 -9.3800
13 C8x C 21.1400 -8.4700
14 C8x C 20.8600 -7.0700
15 N5x N 19.5300 -6.6500
16 O5x O 15.8200 -11.2700
17 C1y C 17.2200 -5.6000
18 C1a C 20.3700 -10.7800
19 C1x C 17.9200 -4.4100
20 C1x C 16.5200 -4.4100
BOND 23
1 3 4 1
2 1 5 1
3 4 6 1
4 2 3 1
5 5 7 1
6 1 2 1
7 6 7 1
8 3 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 2 11 2
13 7 12 2
14 12 13 1
15 13 14 2
16 14 15 1
17 6 15 2
18 1 16 2
19 4 17 1
20 12 18 1
21 19 20 1
22 20 17 1
23 17 19 1
|
|---|
